Download Free Sample Report

The global Atropine Sulfate Injection market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
0.5 mg/mL Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Atropine Sulfate Injection include Pfizer, American Regent, Hikma Pharmaceuticals, Apotex, Amneal Pharmaceuticals, Accord Healthcare, China Res Double-Crane, Hebei Kaiwei Pharmaceutical and Hebei Tiancheng Pharmaceutical, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Atropine Sulfate Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Atropine Sulfate Injection. This report contains market size and forecasts of Atropine Sulfate Injection in global, including the following market information:

• Global Atropine Sulfate Injection Market Revenue, 2019-2024, 2025-2030, ($ millions)
• Global Atropine Sulfate Injection Market Sales, 2019-2024, 2025-2030, (K Units)
• Global top five Atropine Sulfate Injection companies in 2023 (%)

We surveyed the Atropine Sulfate Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Atropine Sulfate Injection Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Atropine Sulfate Injection Market Segment Percentages, by Type, 2023 (%)

• 0.5 mg/mL
• 1 mg/ml
• 5 mg/ml
• Other

Global Atropine Sulfate Injection Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Atropine Sulfate Injection Market Segment Percentages, by Application, 2023 (%)

• Online Sales
• Offline Sales

Global Atropine Sulfate Injection Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Atropine Sulfate Injection Market Segment Percentages, By Region and Country, 2023 (%)

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
• The Middle East and Africa (Middle East, Africa)
• South and Central America (Brazil, Argentina, Rest of SCA)

Competitor Analysis
The report also provides analysis of leading market participants including:

• Key companies Atropine Sulfate Injection revenues in global market, 2019-2024 (Estimated), ($ millions)
• Key companies Atropine Sulfate Injection revenues share in global market, 2023 (%)
• Key companies Atropine Sulfate Injection sales in global market, 2019-2024 (Estimated), (K Units)
• Key companies Atropine Sulfate Injection sales share in global market, 2023 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• American Regent
• Hikma Pharmaceuticals
• Apotex
• Amneal Pharmaceuticals
• Accord Healthcare
• China Res Double-Crane
• Hebei Kaiwei Pharmaceutical
• Hebei Tiancheng Pharmaceutical
• Tai Yu Chemical & Pharmaceutical
• Tianjin Jinyao Pharmaceutical
• Sunflower Pharmaceutical
• China Shineway Pharm
• CSPC Ouyi Pharmaceutical
• Suicheng Pharmaceutical
• Chengdu Brilliant Pharmaceutical
• Anhui Changjiang Pharmaceutical
• Shanghai Harvest Pharmaceutical
• Hubei Xinghua Pharmaceutical
• Changzhou Pharmaceutical Factory

Outline of Major Chapters:
Chapter 1: Introduces the definition of Atropine Sulfate Injection, market overview.
Chapter 2: Global Atropine Sulfate Injection market size in revenue and volume.
Chapter 3: Detailed analysis of Atropine Sulfate Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Atropine Sulfate Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Atropine Sulfate Injection capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.